Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 17,845-17,856 of 23,847
Drug study icon
CompletedNCT01786239

Omega-3 Dietary Supplements in Schizophrenia

This study exists to compare options and see whether questionnaires and follow-up reports offers something meaningfully different. Researchers are trying to understand whether questionnaires and follow-up reports can give earlier or clearer feedback during care.

In Glen Oaks
Schizophrenia, BipolarityDrugA study involving a medication or substance.From 15 Years to 40 Years
Countries
United States
Sponsor
Delbert Robinson
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT01399827

Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With Deficient Emotional Self-Regulation Traits

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In Boston
ADHDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
ADHD
Drug study icon
CompletedNCT00833976

Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia

This study exists to see whether blood tests and biological markers is workable and worth testing more broadly. Researchers are trying to understand what blood tests and biological markers could change in day-to-day care and decision-making.

In Boston
Schizophrenia, BipolarityDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT00644423

Omega-3 Fatty Acids and PTSD (PTSD)

This summary needs review. Please check the official study record and contact the research team for details.

In Durham
PTSDDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Durham VA Medical Center
Condition
PTSD
Behavioral study icon
TerminatedNCT01778647

Omega-3 Fatty Acids as an Adjunctive Therapy for Stimulants in Children With ADHD

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In Brooklyn
ADHDOtherFrom 6 Years to 15 Years
Countries
United States
Sponsor
Antonios Likourezos
Condition
ADHD
Drug study icon
CompletedNCT04417595

Omega-3 Fatty Acids for Smoking Cessation in Pregnancy

This summary needs review. Please check the official study record and contact the research team for details.

In Nashville
AddictionDrugFrom 16 Years to 40 Years
Countries
United States
Sponsor
Vanderbilt University Medical Center
Condition
Addiction
Drug study icon
CompletedNCT00010868

Omega-3 Fatty Acids in Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Belmont
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
National Center for Complementary and Integrative Health (NCCIH)
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.